PET/MRI for the Staging of Newly Diagnosed Prostate Cancer
PET/MRI for the Staging of Newly Diagnosed Prostate Cancer
Active, not recruiting · NCT03392181 · Registry updated 2025-05-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PET/MRI for the Staging of Newly Diagnosed Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Early phase 1 | 2025-05-23 | NCT03392181 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Northwestern University | 381 |
| Progenics Pharmaceuticals, Inc. | 8 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Northwestern University | Chicago | United States | 727 |